AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
1.380
-0.090 (-6.12%)
Dec 5, 2025, 4:00 PM EST - Market closed

AIM ImmunoTech Market Cap

AIM ImmunoTech has a market cap or net worth of $3.94 million as of December 5, 2025. Its market cap has decreased by -73.22% in one year.

Market Cap
3.94M
Enterprise Value
3.87M
1-Year Change
-73.22%
Ranking
n/a
Category
Stock Price
$1.38

Market Cap Chart

Since December 1, 1998, AIM ImmunoTech's market cap has decreased from $159.10M to $3.94M, a decrease of -97.53%. That is a compound annual growth rate of -12.79%.

History

DateMarket Cap% Change
Dec 4, 20254.20M-66.67%
Dec 31, 202412.60M-41.40%
Dec 29, 202321.50M43.33%
Dec 30, 202215.00M-65.91%
Dec 31, 202144.00M-39.56%
Dec 31, 202072.80M1,517.78%
Dec 31, 20194.50M-48.28%
Dec 31, 20188.70M-20.91%
Dec 29, 201711.00M-33.73%
Dec 30, 201616.60M-16.58%
Dec 31, 201519.90M-60.20%
Dec 31, 201450.00M12.61%
Dec 31, 201344.40M17.15%
Dec 31, 201237.90M43.02%
Dec 30, 201126.50M-60.27%
Dec 31, 201066.70M-10.23%
Dec 31, 200974.30M166.31%
Dec 31, 200827.90M-50.09%
Dec 31, 200755.90M-60.04%
Dec 29, 2006139.90M19.27%
Dec 30, 2005117.30M24.79%
Dec 31, 200494.00M10.33%
Dec 31, 200385.20M24.56%
Dec 31, 200268.40M-50.18%
Dec 31, 2001137.30M-2.21%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 925.43B
Johnson & Johnson 494.70B
AbbVie 406.92B
UnitedHealth Group 307.72B
AstraZeneca 283.29B
Novartis AG 257.47B
Merck & Co. 253.84B
Thermo Fisher Scientific 218.08B
Market Cap Rankings